Anzeige
Mehr »
Login
Samstag, 02.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1H8HQ | ISIN: CA87609B1076 | Ticker-Symbol:
Branche
Rohstoffe
Aktienmarkt
Sonstige
1-Jahres-Chart
TARANIS RESOURCES INC Chart 1 Jahr
5-Tage-Chart
TARANIS RESOURCES INC 5-Tage-Chart
ACCESSWIRE
360 Leser
Artikel bewerten:
(2)

Taranis Resources, Inc.: Canada Revenue Agency Reverses Decision, Allowing CEE-Eligibility for 10,000 tonne Bulk Sample at Thor

ESTES PARK, CO / ACCESSWIRE / January 25, 2024 / Taranis Resources Inc. ("Taranis" or the "Company") (TSX.V:TRO)(OTCQB:TNREF) is pleased to announce that the Canada Revenue Agency ("CRA") has reversed its 2021 ruling that disallowed the use of Canadian Exploration Expenses ("CEE") treatment for certain expenditures incurred in 2017 and 2018 related to the permitting of the 10,000 tonne exploration Bulk Sample. This ruling was made in response to the Company's "Request for Loss Determination for the taxation years ended December 31, 2017 and December 31, 2018" which it filed on February 1, 2022.

History of Bulk Sample Permitting at Thor

Taranis submitted a Joint Environmental and Mines Act ("JEMA") Permit application to the government of British Columbia on October 15, 2018. Pre-Screening began on January 15, 2019 and was completed on September 16, 2019. On September 16, 2019, the Permit application proceeded to Technical Review. During the Technical Review process, twenty-three (23) government reviewers provided commentary on the application. During the Technical Review period, Taranis performed numerous studies that included water quality baseline studies, engineering construction reports and environmental studies at an estimated cost of almost C$1M. The Mines Act Permit was issued on June 17, 2021 after the B.C. Ombudsperson's Office investigated lengthy governmental delays and inconsistent policy implementation with the Permit application.

Canda Revenue Agency ("CRA") Audit of CEE-eligibility of Exploration 10,000 tonne Bulk Sample

In January of 2020, the CRA informed Taranis that it would be conducting an audit of 2017-2018 CEE expenditures. On August 30, 2021, the CRA informed Taranis that it was disallowing permitting regarding its Bulk Sample to be eligible for CEE, because "the expenditures are excessive for an exploration Bulk Sample". Taranis was able to successfully argue that the costs for such an exploration Bulk Sample were mandated by the British Columbia government under the JEMA. Shortly thereafter, the CRA formulated a new rationale and said "the Bulk Sample was not processing a Mineral Resource" because it drew on broken ore stockpiles in the True Fissure Open Pit. Again, Taranis was able to successfully demonstrate that stockpiles do constitute part of Mineral Resources, and therefore meet the purpose test. Finally, on January 22, 2021, the CRA issued its Final Letter and said that "Taranis was seeking an Optimal Method" for processing the stockpiled material. Taranis was not given the opportunity to comment on the CRA's Final Letter, and the only recourse was to file a "Request for Loss Determination" for the taxation years ended December 31, 2017 and 2018. Finally, on January 9, 2024, Taranis was informed that the CRA Appeals Division had completed its review and that the 10,000 tonne Bulk Sample permitting costs were in fact CEE eligible, thus reversing CRA's previous position.

Engineering Site Investigation Completed

Once Taranis had received notice that the CRA was disallowing CEE treatment of certain costs relating to the exploration 10,000 tonne Bulk Sample, Taranis discontinued spending on the venture until such time as a decision could be made on the CEE-Eligibility. Now that this issue has been resolved to the Company's satisfaction, Taranis intends on moving forward. In that regard, Taranis has submitted an engineering report prepared by Knight Piésold to the Province of British Columbia's Ministry of Energy, Mines and Low Carbon Innovation as part of the documentation that is necessary prior to construction of the bulk sample processing facility.

Comment

John Gardiner, President and CEO, states, "We have worked tirelessly to ensure that our exploration 10,000 tonne Bulk Sample was properly treated as an exploration activity for our shareholders. This is an important step toward completing an eventual economic assessment of the Mineral Resource at Thor. Taranis had a professional responsibility to bring this issue to the attention of knowledgeable industry representative groups. Consequently, we had numerous discussions with the Prospectors and Developers Association of Canada regarding the CEE eligibility issue. Our guiding principle on this is 'Do what's right and right will follow.' Exploration companies should be first and foremost concerned with undertaking safe and environmentally sound exploration, and should not be perpetually countering misdirected permitting and tax issues which are being weaponized by the B.C. government. In British Columbia, there is substantial room for improvement permitting exploration projects; and making tardy or incorrect policy/regulatory decisions has adverse consequences on capital availability to industry in the province. The industry is in decline in British Columbia which saw a $100M drop in exploration expenditures in 2023 - a trend that is only going to accelerate in 2024. It is ironic that although the provincial government trumpets the desire to produce strategic metals, and assures the sector that "Once you make your investments in British Columbia, then your investments are safe", reality has demonstrated that nothing could be further removed from the reality of B.C.'s exploration/mining sector.

For additional information on Taranis or its 100%-owned Thor project in British Columbia, visit www.taranisresources.com

Taranis currently has 94,587,027 shares issued and outstanding (109,262,027 shares on a fully-diluted basis).

TARANIS RESOURCES INC.
Per: John J. Gardiner (P. Geo.), President and CEO

For further information contact:

John J. Gardiner
681 Conifer Lane
Estes Park, Colorado 80517
Phone: (303) 716-5922 Cell: (720) 209-3049 johnjgardiner@earthlink.net

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE.

This News Release may contain forward looking statements based on assumptions and judgments of management regarding future events or results that may prove to be inaccurate as a result of factors beyond its control, and actual results may differ materially from expected results.

SOURCE: Taranis Resources, Inc.



View the original press release on accesswire.com

© 2024 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.